Corporate Governance Reports
Overview
Board of Directors
Accountability and Audit
Shareholders
Compliance to Code
 
COMPLIANCE TO CODE

The Group has complied throughout the financial year with all the best practices of corporate governance set out in Part 2 of the Code, except Best Practice AAVVII (Nomination of a Senior Independent Non-Executive Director). Given the current composition of the Board which reflects a strong independent element and the separation of the roles of the Chairman and the Chief Executive Officer, the Board does not consider it necessary at this juncture to nominate a Senior Independent Non-Executive Director.

 
  Solutions by WEBSEImportant legal information - please read the Privacy Policy & Disclaimer before proceeding.
Copyright © 2010 CCM Duopharma Biotech Bhd. All Rights Reserved.